Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Obesity paradox in heart failure: statistical artifact, or impetus to rethink clinical practice?

Charnigo R, Guglin M.

Heart Fail Rev. 2016 Aug 27. [Epub ahead of print] Review.

PMID:
27567626
2.

Characteristics and outcomes of patients with acute systolic heart failure discharged within 48hours: A qualification for "observation status" hospital admission.

Omar HR, Guglin M.

Int J Cardiol. 2016 Aug 7;223:129-132. doi: 10.1016/j.ijcard.2016.08.092. [Epub ahead of print] No abstract available.

PMID:
27537738
3.

Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.

Omar HR, Guglin M.

Int J Cardiol. 2016 Oct 15;221:1116-22. doi: 10.1016/j.ijcard.2016.07.117. Epub 2016 Jul 9.

PMID:
27467969
4.

Longitudinal BNP follow-up as a marker of treatment response in acute heart failure: Relationship with objective markers of decongestion.

Omar HR, Guglin M.

Int J Cardiol. 2016 Oct 15;221:167-70. doi: 10.1016/j.ijcard.2016.06.174. Epub 2016 Jun 27.

PMID:
27400316
5.

Hypothermia is an independent predictor of short and intermediate term mortality in acute systolic heart failure: Insights from the ESCAPE trial.

Omar HR, Guglin M.

Int J Cardiol. 2016 Oct 1;220:729-33. doi: 10.1016/j.ijcard.2016.06.166. Epub 2016 Jun 25.

PMID:
27393856
6.

Sildenafil in heart failure with reactive pulmonary hypertension (Sildenafil HF) clinical trial (rationale and design).

Guglin M, Rajagopalan N, Anaya P, Charnigo R.

Pulm Circ. 2016 Jun;6(2):161-7. doi: 10.1086/685548.

7.

Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes.

Omar HR, Guglin M.

Int J Cardiol. 2016 Sep 1;218:120-5. doi: 10.1016/j.ijcard.2016.05.038. Epub 2016 May 13.

PMID:
27232923
8.

A single BNP measurement in acute heart failure does not reflect the degree of congestion.

Omar HR, Guglin M.

J Crit Care. 2016 Jun;33:262-5. doi: 10.1016/j.jcrc.2016.02.023. Epub 2016 Mar 8.

PMID:
27040515
9.

Pheochromocytoma and takotsubo.

Guglin M.

Int J Cardiol. 2016 Jan 1;202:952. doi: 10.1016/j.ijcard.2015.10.031. Epub 2015 Nov 6. No abstract available.

PMID:
26549561
10.

Who wants a left ventricular assist device for ambulatory heart failure? Early insights from the MEDAMACS screening pilot.

Stewart GC, Kittleson MM, Cowger JA, Johnson FL, Patel CB, Mountis MM, Patel PC, Rame JE, Testani J, Guglin ME, Teuteberg JJ, Stevenson LW.

J Heart Lung Transplant. 2015 Dec;34(12):1630-3. doi: 10.1016/j.healun.2015.07.009. Epub 2015 Aug 4. No abstract available.

PMID:
26321249
11.

Iatrogenic takotsubo cardiomyopathy.

Guglin M.

Int J Cardiol. 2015 Jul 1;190:183-4. doi: 10.1016/j.ijcard.2015.04.174. Epub 2015 Apr 22. No abstract available.

PMID:
25918076
12.

Short-term mechanical circulatory support: the problem of the uninsured.

Rajagopalan N, Guglin M, Hoopes CW.

J Am Coll Cardiol. 2015 Mar 17;65(10):1062-3. doi: 10.1016/j.jacc.2014.11.063. No abstract available.

13.

Computerized auditory cognitive training to improve cognition and functional outcomes in patients with heart failure: Results of a pilot study.

Athilingam P, Edwards JD, Valdes EG, Ji M, Guglin M.

Heart Lung. 2015 Mar-Apr;44(2):120-8. doi: 10.1016/j.hrtlng.2014.12.004. Epub 2015 Jan 12.

PMID:
25592205
14.

The role of biventricular pacing in the prevention and therapy of pacemaker-induced cardiomyopathy.

Guglin M, Barold SS.

Ann Noninvasive Electrocardiol. 2015 May;20(3):224-39. doi: 10.1111/anec.12245. Epub 2015 Jan 6. Review.

PMID:
25564929
15.

Success of left ventricular assist device therapy in uninsured patients.

Rajagopalan N, Guglin M, Million K, Yanagida R, Hoopes CW.

Int J Cardiol. 2014 Dec 20;177(3):1087-8. doi: 10.1016/j.ijcard.2014.10.001. Epub 2014 Oct 7. No abstract available.

PMID:
25456705
16.

Heart failure as a risk factor for diabetes mellitus.

Guglin M, Lynch K, Krischer J.

Cardiology. 2014;129(2):84-92. doi: 10.1159/000363282. Epub 2014 Aug 19.

17.

Inotropes do not increase mortality in advanced heart failure.

Guglin M, Kaufman M.

Int J Gen Med. 2014 May 20;7:237-51. doi: 10.2147/IJGM.S62549. eCollection 2014. Review.

18.

How to increase the utilization of donor hearts?

Guglin M.

Heart Fail Rev. 2015 Jan;20(1):95-105. doi: 10.1007/s10741-014-9434-y. Review.

PMID:
24858482
19.

Myocarditis with normal left ventricular function and troponin of 266.

Ramos-Matos C, Scholfield M, Fontuoro J, Rojas CA, Guglin M.

Am J Emerg Med. 2014 Nov;32(11):1443.e1-2. doi: 10.1016/j.ajem.2014.04.034. Epub 2014 Apr 24.

PMID:
24856753
20.

Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial.

Scholfield M, Schabath MB, Guglin M.

J Card Fail. 2014 Jul;20(7):476-84. doi: 10.1016/j.cardfail.2014.05.001. Epub 2014 May 15.

PMID:
24845963
Items per page

Supplemental Content

Loading ...
Write to the Help Desk